Achieve Life Sciences, Inc. Finance Lease, Liability, Current
Achieve Life Sciences, Inc. (ACHV) had Finance Lease, Liability, Current of $16.00 thousand as of 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2019-08-08
- 2019-06-30: Finance Lease, Liability, Current $16.00K.
- 2019-03-31: Finance Lease, Liability, Current $16.00K.
- 2018-12-31: Finance Lease, Liability, Current $11.00K.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2019-06-30 | $16.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $16.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $11.00K 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |